Can I Take 4.8mg of Wegovy — or Is That Not How the Dose Schedule Works?

Why 4.8mg appears in searches but not in any UK prescription

The question comes up regularly, and it is worth understanding why. Semaglutide exists in several formulations at different strengths, and not all of them are for weight loss. Rybelsus, the oral semaglutide tablet licensed for type 2 diabetes, comes in 3mg, 7mg and 14mg strengths. Ozempic, the injectable semaglutide for diabetes, uses a 0.5mg and 1.0mg dosing mechanism. The Wegovy injection, licensed for weight management, uses a completely separate titration schedule.

None of these products include a 4.8mg dose, and combining any of them to reach that number is not something any prescriber would advise. The figure may also arise from a misreading of American sources: the US market has its own product labelling and, in some cases, compounded semaglutide has been sold at non-standard doses, none of which applies to licensed UK supply. If you want a clear account of every Wegovy dose available in the UK, that page covers the full schedule with the source references.

The short answer: 4.8mg is not a Wegovy dose, and that page explains in detail why this figure appears online and what it actually refers to. If your prescription says something different, contact your prescriber directly.

The decision your prescriber is actually making at each dose review

When a prescriber moves you up the Wegovy schedule, they are weighing tolerability against therapeutic effect, not simply going as fast as possible. The 0.25mg starting dose exists purely to let your body adjust; nausea and other gastrointestinal effects tend to be more pronounced early on, and the gradual step-up is the mechanism for managing that.

Each four-week step gives the prescriber information: how did you tolerate the last dose, is weight reduction on track, are there any new symptoms worth discussing? That review matters. Wegovy's full profile as a licensed weight management medicine goes into more detail on how semaglutide works and what the clinical evidence shows for each phase of treatment.

The MHRA's approval of a 7.2mg maintenance dose (confirmed in April 2026, initially supplied as three 2.4mg pens weekly and now also available as a dedicated single-dose pen) extended the top of the ladder for adults with a BMI of 30 or above. Even that extension is reached through the same staged review process, not by skipping steps. Specific dose availability at any given time is confirmed at consultation, since supply can vary.

What happens if you take more Wegovy than prescribed

This is a question our prescribers hear more often than you might expect, usually from people who feel their progress has stalled and want to do something about it. Taking a higher dose than prescribed, or taking a dose more frequently than weekly, is not a clinical short-cut, it is a medication error.

Semaglutide's side-effect profile is dose-dependent. Nausea, vomiting, diarrhoea and other gastrointestinal symptoms intensify at higher doses, and severe vomiting or diarrhoea can lead to dehydration and put real pressure on your kidneys. There is also a known but infrequent risk of acute pancreatitis with GLP-1 medicines; the MHRA's Yellow Card scheme exists precisely so that suspected adverse effects (including those from dose errors) are captured and reported. If you have accidentally taken too much, contact your prescriber or NHS 111 the same day.

For background on how doubling a dose of Wegovy affects the body, that page covers the risks in full. And if you are unsure whether your current dose is right for where you are in treatment, that is a conversation to have with your prescriber, not something to resolve by experimenting.

If you are wondering whether Wegovy is the right treatment for you

Eligibility for Wegovy in a private setting follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. A UK prescriber assesses the full picture (not just a BMI figure) and decides whether semaglutide, tirzepatide, or another approach suits your situation best.

The cost of Wegovy through a private pharmacy is worth understanding before you start, since private pricing varies by dose and provider. On the NHS, access follows NICE guidance (TA875), which currently requires referral to a specialist weight management service, waiting lists are long in most areas, which is why many people explore the private route.

You might also find it useful to read about whether taking half a dose of Wegovy is ever appropriate, particularly if tolerability at your current step has been difficult. As with all dosing decisions, it is one to raise with your prescriber rather than act on independently. A good place to start is a free consultation, your answers are reviewed the same day by a GPhC-registered prescriber, not a piece of software. Check your eligibility at our treatment overview and see what is clinically right for you.